XML 92 R72.htm IDEA: XBRL DOCUMENT v3.25.0.1
Impairments and Exit Costs (Provision for Impaired Assets and Restaurant Closings) (Details)
$ in Thousands
12 Months Ended
Dec. 29, 2024
USD ($)
Restaurants
Dec. 31, 2023
USD ($)
Dec. 25, 2022
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Provision for impaired assets and restaurant closings $ 64,291 $ 33,574 $ 5,964
Provision for impaired assets and restaurant closings      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Impairment losses 46,435 40,412 5,486
Restaurant closure (benefits) charges 17,856 (6,838) 478
Provision for impaired assets and restaurant closings $ 64,291    
HONG KONG      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Number of restaurants | Restaurants 9    
Other | Provision for impaired assets and restaurant closings      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Impairment losses $ 12,488 [1] 600 1,537
Restaurant closure (benefits) charges 3,811 [1] 305 0
Corporate | Provision for impaired assets and restaurant closings      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Impairment losses 0 0 7
U.S. segment | Provision for impaired assets and restaurant closings      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Impairment losses 33,947 [2] 39,812 [2] 3,942
Restaurant closure (benefits) charges $ 14,045 [2] $ (7,143) [2] $ 478
[1] Primarily includes charges related to the 2024 closure of nine restaurants in Hong Kong.
[2] Primarily includes charges related to the 2023 Restaurant Closures and the Q4 2024 Restaurant Impairment, as discussed below.